Doctolib executed a strategic acquisition of Medicus, a UK-based developer of clinical software for the National Health Service (NHS), marking its official entry into the United Kingdom. This transaction represents a key milestone in Doctolib's European expansion, adding the UK as its fifth operational market alongside France, Germany, Italy, and the Netherlands. The acquisition is driven by a shared mission to address systemic challenges within healthcare, particularly the increasing demand for care and the significant administrative burden placed on medical professionals. By integrating Medicus, Doctolib gains an immediate and strong foothold in the UK's primary care sector. Medicus is recognized for having developed the first new software for general practitioners in the NHS in over two decades, successfully disrupting a market dominated by two incumbents. The rationale behind the deal is to combine Medicus's deep understanding of the NHS and its user-centric platform with Doctolib's extensive technological expertise, particularly in artificial intelligence and scalable software solutions. The synergy is expected to accelerate the development and deployment of a more comprehensive product suite for UK GPs, focusing on innovations that simplify clinical documentation, automate workflows, and ultimately allow healthcare providers to dedicate more time to patient care.

MEDICUS, which reported an EBITDA margin of LOGIN in 2026, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (13.3x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.